Πλοήγηση ανά Συγγραφέα "Daliani, D."
-
Revisiting bleomycin from pathophysiology to safe clinical use
Froudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E. (2013)Bleomycin is a key component of curative chemotherapy regimens employed in the treatment of curable cancers, such as Hodgkin lymphoma (HL) and testicular germ-cell tumours (GCT), yet its use may cause bleomycin-induced ... -
Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: A focus beyond ejaculation disorders
Dimitropoulos, K.; Karatzas, A.; Papandreou, C.; Daliani, D.; Zachos, I.; Pisters, L. L.; Tzortzis, V. (2015)Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) represents an integral part of multidisciplinary treatment of advanced germ cell cancer; however, it is associated with a high complications rate. The ... -
Simple and Reliable HPLC Method for the Monitoring of Methotrexate in Osteosarcoma Patients
Begas, E.; Papandreou, C.; Tsakalof, A.; Daliani, D.; Papatsibas, G.; Asprodini, E. (2014)Methotrexate (MTX) is a dihydrofolate reductase inhibitor that is used for the treatment of tumors and autoimmune diseases. Several automated binding assays are used in clinical practice and numerous chromatographic methods ...